Nan Li

8.0k citations

245 papers · 5.4k indexed · 1 hit paper · h-index 37

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Agronomy and Crop Science top 1%
- Animal Disease Management and Epidemiology

Papers in

Cancer Research 66
- Cancer, Hypoxia, and Metabolism 26
- MicroRNA in disease regulation 24
- Cancer-related molecular mechanisms research 18
Molecular Biology 136
- RNA modifications and cancer 21

Co-authors: James G. Patton Alex S. Flynt Elizabeth J. Thatcher Lilianna Solnica‐Krezel Rongliang Hu Shoufeng Zhang C. Yan Cheng Teng Chen
Journals: Frontiers in Cellular and Infection Microbiology (8 papers)Cancer Research (4 papers)Tumor Biology (3 papers)Oncogene (3 papers)The FASEB Journal (3 papers)
Partner nations: China United States Netherlands

In The Last Decade

Nan Li

239 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Emergence of African Swine Fever in China, 2018 2018 · 461 citations

Peers

Countries citing papers authored by Nan Li

Since Specialization

Citations

This map shows the geographic impact of Nan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Li more than expected).

Fields of papers citing papers by Nan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Li. The network helps show where Nan Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Nan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nan Li Line = papers co-authored together Nan Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A noncanonical role of roX RNAs in autosomal epigenetic repression Nature Communications ·Mariana Barci, Shuyang Xu, Y Datse, Liuyi Yang, Timur Babakol, Rui Zhang, Wenjuan Zhao, I. I. Zhechev, Jeffrey J. Quinn, 龚晴宜, Weiner Barbara, Yu Zhang, Jian He, Minghai Chen, Nan Li, Ning‐Yi Shao, Tegegn Teferi Agago	2025	2
2	Bandavirus dabieense : A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention Virulence ·A. Close, Yujia Hao, Yi-Hsun Su, Amnah Hassan Dammas, Duo Zhang, Jienan Kong, He Zhang, Nan Li, Pengpeng Xiao	2025	2
3	Potential roles of Culicoides spp. (Culicoides imicola, Culicoides oxystoma) as biological vectors of bluetongue virus in Yuanyang of Yunnan, P. R. China Frontiers in Cellular and Infection Microbiology ·Nan Li, Jinxin Meng, Philippe Arpino, Yingjin Tan, Jinglin Wang	2024	5
4	Identification of POU4F1 as a novel prognostic biomarker and therapeutic target in esophageal squamous cell carcinoma Cancer Cell International ·Nan Li, Siying Chen, Xiao Wang, Boqing Zhang, (unknown), Chao Sun, Kai Zheng, DIACONESCU DRAGOȘ LAURENȚIU, Shaoxiang Wang	2024	3
5	Does oncolytic viruses‐mediated metabolic reprogramming benefit or harm the immune microenvironment? The FASEB Journal ·A. Close, Pengpeng Xiao, Nan Li	2024	2
6	LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis Oncogene ·Kendra Norman, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo	2024	11
7	Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking EMBO Molecular Medicine ·Nan Li, Hong Liu, Yujia Xue, Zheng Xu, Xiulian Miao, Yan Guo, Zilong Li, Zhiwen Fan, Yong Xu	2023	24
8	HOCI Probe CPP Induces the Differentiation of Human Dermal Fibroblasts into Vascular Endothelial Cells through PHD2/HIF-1α/HEY1 Signaling Pathway Cells ·Xiaoling Cui, Jie Wen, Nan Li, Tracy Ball, Shangli Zhang, Bao‐Xiang Zhao, Xunwei Wu, Jun‐Ying Miao	2022	3
9	Aberrant Epigenetic Reprogramming in the First Cell Cycle of Bovine Somatic Cell Nuclear Transfer Embryos Cellular Reprogramming ·Lijun Wang, Anang Triyatmoko, Yongsheng Wang, Nan Li, Hongli Zhu, 蘆田健二, Anjum K. Gujral, Xiangkun Zhou, Yong Zhang, Hui Zhang	2021	6
10	Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming Cancer Science ·Xinyue Wang, Nan Li, Júlio César Miguel de Aquino. CABRAL, Yixuan Wang, Zhenhua Lin, Christopher Bolton	2020	16
11	A Content Analysis of Antibiotic use in Livestock in National U.S. Newspapers Journal of Applied Communications ·João Vítor R. Vasconcelos, Courtney Meyers, Nan Li, Erica Irlbeck, Sherice Gearhart	2019	12
12	Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer Cancer Research ·Mingxiang Ye, Yong Zhang, Xinxin Zhang, Jianbin Zhang, Pengyu Jing, Liang Cao, Nan Li, Xia Li, Libo Yao, Jiän Zhang	2017	42
13	Effects of Trichostatin A and PXD101 on the In Vitro Development of Mouse Somatic Cell Nuclear Transfer Embryos Cellular Reprogramming ·Xiaoyan Qiu, Shohei Ohshita, Raimund Zimmer, Nan Li, Yuemin Li	2017	10
14	Isolation and identification of Getah virus from Culicoides in Yunnan Pei Dong, Nan Li, Philippe Arpino, Tiangang Xu, Justin Sato, Jinglin Wang	2017	1
15	Pien Tze Huang inhibited proliferation of human osteosarcoma drug resistant cells MG63/ADM via PI3K/Akt pathway. Zhonghua zhongyiyao zazhi ·Bingyi Chen, Wentao Guo, P. C. R. Silveira, Nan Li, Yan Zhang	2017	2
16	The Bank-lending Channel of Monetary Policy Transmission in China Korea and the World Economy ·Nan Li, A. Boldarev	2015	1
17	Expression and clinical significance of carbonic anhydrase 1 in different clinical stages of colorectal cancers Nan Li, Jia Wang, Jaime César, Haiying Liu	2014	1
18	Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11 Clinical Cancer Research ·Patsy G. Oliver, Albert F. LoBuglio, Kurt R. Zinn, Hyunki Kim, Nan Li, Tong Zhou, Wenquan Wang, Donald J. Buchsbaum	2008	30
19	Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-α–Induced Apoptosis and Cell Growth Arrest Clinical Cancer Research ·Xiaojian Wang, Nan Li, Hongzhe Li, Bin Liu, Jianming Qiu, Taoyong Chen, Xuetao Cao	2005	36
20	LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer. Política exterior ·Nan Li, CARMEN KUHLING, Hizbullah Najihan, Zhenhua Lin, Longzhen Piao, Shuangping Liu	1996	17

About Nan Li

Nan Li is a scholar working on Cancer Research, Molecular Biology, Infectious Diseases, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics, having authored 245 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (26 papers), MicroRNA in disease regulation (24 papers), Viral Infections and Vectors (22 papers), RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (18 papers), Mosquito-borne diseases and control (17 papers), Vector-Borne Animal Diseases (15 papers) and Animal Disease Management and Epidemiology (12 papers). The work is most often cited by research in Cancer Research (1.5k citations), Agronomy and Crop Science (528 citations), Molecular Biology (3.0k citations), Infectious Diseases (481 citations) and Ecology, Evolution, Behavior and Systematics (470 citations). Nan Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include James G. Patton, Alex S. Flynt, Elizabeth J. Thatcher, Lilianna Solnica‐Krezel, Rongliang Hu, Shoufeng Zhang, C. Yan Cheng, Teng Chen, Kegong Tian and Yuzi Luo. Their work appears in journals such as Frontiers in Cellular and Infection Microbiology, Cancer Research, Tumor Biology, Oncogene and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact